Darbagen IV/SC 60 mcg/0.3 ml is a Product of the Generic Darbepoetin Alfa

Darbagen IV/SC 60 mcg/0.3 ml belongs to the generic category of Darbepoetin Alfa. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Darbagen IV/SC 60 mcg/0.3 ml. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Darbepoetin Alfa and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Description of Darbagen IV/SC 60 mcg/0.3 ml

Darbagen IV/SC 60 mcg/0.3 ml may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Darbagen IV/SC 60 mcg/0.3 ml is provided below to help users gain a clear understanding of this medicine.

What Is Darbagen IV/SC 60 mcg/0.3 ml Indications and Uses?

Darbagen is indicated for the treatment of anemia due to: Chronic Kidney Disease (CKD) in patients on dialysis and patients not on dialysis. The effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.

Pharmacology (Source, Chemical and Physical Composition) Of Darbagen IV/SC 60 mcg/0.3 ml

Darbagen IV/SC 60 mcg/0.3 ml (Darbepoetin Alfa) is an erythropoiesis-stimulating protein that is produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology. It is a 165-amino acid protein that differs from recombinant human erythropoietin in containing 5 N-linked oligosaccharide chains, whereas recombinant human erythropoietin contains 3 chains. The 2 additional N-glycosylation sites result from amino acid substitutions in the erythropoietin peptide backbone.

Drug Interactions of Darbagen IV/SC 60 mcg/0.3 ml

No formal drug interaction studies have been conducted with Darbagen.

Side Effects of Darbagen IV/SC 60 mcg/0.3 ml

Hypertension, stroke, thromboembolic events, convulsions, allergic reactions, rash/erythema and Pure Red Cell Aplasia (PRCA).

Precautions And Warnings for Darbagen IV/SC 60 mcg/0.3 ml

Darbagen should be used with caution in patients with controlled hypertension, seizures, Pure Red Cell Aplasia (PRCA) or suspected allergy to the product.

Use During Pregnancy and Lactation

Pregnancy Category C. It is not known whether Darbagen IV/SC 60 mcg/0.3 ml (Darbepoetin Alfa) is excreted in human milk. Caution should be exercised when Darbepoetin alfa is administered to a nursing woman.

Therapeutic Class

Haematopoietic Agents

Storage Conditions of It

Store at 2°C to 8°C. Do not freeze. Do not shake. Protect from light; store Darbagen in the carton until use. Do not use Darbagen that has been shaken or frozen. Pack Image: Darbagen 60 mcg/0.3 ml Injection Thanks for using MedEx! How would you rate your experience so far?